Inactive Instrument

Bionovate Technologies Corp. Stock Other OTC

Equities

BIIO

US09074V2025

Investment Holding Companies

Financials (USD)

Sales 2020	-	Sales 2021	-	Capitalization	19.57M
Net income 2020	-	Net income 2021	-	EV / Sales 2020	-
Net Debt 2020	226K	Net Debt 2021	278K	EV / Sales 2021	-
P/E ratio 2020	-205 x	P/E ratio 2021	-69.1 x	Employees	-
Yield 2020 *	-	Yield 2021	-	Free-Float	50.99%

More Fundamentals * Assessed data

Chart Bionovate Technologies Corp.

Duration

Period

Style

Dynamic Chart

Latest news about Bionovate Technologies Corp.

Bionovate Technologies Corp. Reports Earnings Results for the First Quarter Ended September 30, 2021	21-11-15	CI
Bionovate Technologies Corp. Reports Earnings Results for the Full Year Ended June 30, 2021	21-10-14	CI
Bionovate Technologies Corp Auditor Raises 'Going Concern' Doubt	21-10-13	CI
Bionovate Technologies Corp. Announces Board Changes	21-07-14	CI
Bionovate Technologies Corp. Announces Chief Executive Officer Changes	21-07-14	CI
Bionovate Technologies Corp. Announces CFO Changes	21-07-14	CI
Bionovate Technologies Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2021	21-05-17	CI
Bionovate Technologies Corp. Reports Earnings Results for the Second Quarter Ended December 31, 2020	21-01-28	CI
Bionovate Technologies Corp. Reports Earnings Results for the Full Year Ended June 30, 2020	20-10-19	CI
Bionovate Technologies Corp. Announces Management Changes	20-10-06	CI
Bionovate Technologies Corp. Announces Appointment of Aleksander Vucak as Chief Executive Officer	20-10-06	CI
Bionovate Technologies Corp. Appoints Aleksander Vucak as Chief Financial Officer	20-10-06	CI
Human Data AG acquired 91.3% stake in Bionovate Technologies Corp. from Evergreen Solutions, Ltd.	20-10-05	CI
Bionovate technologies corp. Announces Executive Changes	20-07-23	CI
Bionovate technologies corp. Appoints Marc Applbaum its Chief Financial Officer	20-07-23	CI

More news

Press releases Bionovate Technologies Corp.

BIONOVATE TECHNOLOGIES CORP. : Other Events (form 8-K)	22-02-01	AQ
BIONOVATE TECHNOLOGIES CORP. Management's Discussion and Analysis of Financial Condition or Plan of Operation (form 10-Q)	21-11-15	AQ
BIONOVATE TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	21-10-14	AQ
BIONOVATE TECHNOLOGIES CORP. : Change in Directors or Principal Officers (form 8-K)	21-07-14	AQ
BIONOVATE TECHNOLOGIES : Management's Discussion and Analysis of Financial Condition or Plan of Operation (form 10-Q)	21-05-17	AQ

More press releases

Managers and Directors - Bionovate Technologies Corp.

Managers	Title	Age	Since
Aleksandar Vucak CEO	Chief Executive Officer	52	20-09-27

Members of the board	Title	Age	Since
Aleksandar Vucak CEO	Chief Executive Officer	52	20-09-27

More insiders

Company Profile

Bionovate Technologies Corp., formerly MJP International Ltd., is a shell company. The Company is involved in the review of opportunities for merger and acquisition. The Company has no operations.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+103.83%	4.45B
SCREAMING EAGLE ACQUISITION CORP.	+1.60%	1.01B
CHURCHILL CAPITAL CORP VII	+2.19%	981M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+27.88%	853M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+0.54%	610M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+26.89%	560M

Shell Companies